Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.3, replacing the previous v3.6.1. This indicates a new release of the page but does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-02T03:20:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision is updated from v3.6.0 to v3.6.1, indicating a newer release of the page. This update appears to be an administrative metadata change rather than a content change to the study details.
    Difference
    0.0%
    Check dated 2026-06-25T00:17:51.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recruitment status updated to 'no longer looking for participants' signals enrollment has ended. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, along with a Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-10T17:57:33.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new edition of the page metadata. There are no changes to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-03T09:31:32.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Publications section now lists the NEJM article by Murthy et al. on tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer with full author names and citation details. The previous NEJM entry that included an erratum has been removed.
    Difference
    0.0%
    Check dated 2026-05-20T06:48:22.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added a new revision label v3.5.3 and removed the previous v3.5.2, indicating an updated release version on the page. This appears to be a meta-level update rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-28T08:12:37.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.